Italy
· Delayed Price · Currency is EUR Arterra Bioscience Statistics
Total Valuation
Arterra Bioscience has a market cap or net worth of EUR 12.92 million. The enterprise value is 9.83 million.
| Market Cap | 12.92M |
| Enterprise Value | 9.83M |
Important Dates
The next estimated earnings date is Friday, December 27, 2024.
| Earnings Date | Dec 27, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Arterra Bioscience has 6.66 million shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 6.66M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 41.07% |
| Owned by Institutions (%) | n/a |
| Float | 3.35M |
Valuation Ratios
The trailing PE ratio is 9.61.
| PE Ratio | 9.61 |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | 1.22 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 7.31 |
| EV / Sales | 2.70 |
| EV / EBITDA | 5.42 |
| EV / EBIT | 7.67 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.79, with a Debt / Equity ratio of 0.03.
| Current Ratio | 8.79 |
| Quick Ratio | 7.54 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | 0.19 |
| Debt / FCF | n/a |
| Interest Coverage | 1,785.49 |
Financial Efficiency
Return on equity (ROE) is 13.02% and return on invested capital (ROIC) is 7.45%.
| Return on Equity (ROE) | 13.02% |
| Return on Assets (ROA) | 6.43% |
| Return on Capital (ROIC) | 7.45% |
| Revenue Per Employee | 107,181 |
| Profits Per Employee | 39,553 |
| Employee Count | 34 |
| Asset Turnover | 0.29 |
| Inventory Turnover | 1.53 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +10.86% in the last 52 weeks. The beta is 1.08, so Arterra Bioscience's price volatility has been similar to the market average.
| Beta (5Y) | 1.08 |
| 52-Week Price Change | +10.86% |
| 50-Day Moving Average | 1.95 |
| 200-Day Moving Average | 2.00 |
| Relative Strength Index (RSI) | 49.51 |
| Average Volume (20 Days) | 4,313 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Arterra Bioscience had revenue of EUR 3.64 million and earned 1.34 million in profits.
| Revenue | 3.64M |
| Gross Profit | 2.03M |
| Operating Income | 1.28M |
| Pretax Income | 1.67M |
| Net Income | 1.34M |
| EBITDA | 1.81M |
| EBIT | 1.28M |
| Earnings Per Share (EPS) | n/a |
Balance Sheet
The company has 3.43 million in cash and 342,970 in debt, giving a net cash position of 3.08 million or 0.46 per share.
| Cash & Cash Equivalents | 3.43M |
| Total Debt | 342,970 |
| Net Cash | 3.08M |
| Net Cash Per Share | 0.46 |
| Equity (Book Value) | 10.60M |
| Book Value Per Share | n/a |
| Working Capital | 6.83M |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 55.64%, with operating and profit margins of 35.18% and 36.90%.
| Gross Margin | 55.64% |
| Operating Margin | 35.18% |
| Pretax Margin | 45.82% |
| Profit Margin | 36.90% |
| EBITDA Margin | 49.79% |
| EBIT Margin | 35.18% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.10, which amounts to a dividend yield of 5.15%.
| Dividend Per Share | 0.10 |
| Dividend Yield | 5.15% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 2 |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | 5.15% |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Arterra Bioscience has an Altman Z-Score of 5.86.
| Altman Z-Score | 5.86 |
| Piotroski F-Score | n/a |